AR017513A1 - Preparado farmaceutico combinado que contiene un inhibidor del intercambiador entre sodio e hidrogeno y envase comercial destinado al tratamientode enfermedades cardiocirculatorias - Google Patents

Preparado farmaceutico combinado que contiene un inhibidor del intercambiador entre sodio e hidrogeno y envase comercial destinado al tratamientode enfermedades cardiocirculatorias

Info

Publication number
AR017513A1
AR017513A1 ARP980104222A ARP980104222A AR017513A1 AR 017513 A1 AR017513 A1 AR 017513A1 AR P980104222 A ARP980104222 A AR P980104222A AR P980104222 A ARP980104222 A AR P980104222A AR 017513 A1 AR017513 A1 AR 017513A1
Authority
AR
Argentina
Prior art keywords
exchanger
treatment
pharmaceutical preparation
sodium
hydrogen
Prior art date
Application number
ARP980104222A
Other languages
English (en)
Original Assignee
Gompel Marie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gompel Marie filed Critical Gompel Marie
Publication of AR017513A1 publication Critical patent/AR017513A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Preparado farmacéutico, caracterizado porque contiene un inhibidor del intercambiador entre Na+ y H+ y una sustancia activa sobre el corazon y lacirculacion. En este caso, tales combinaciones de un inhibidor del NHE pueden constar de uno o varios componentes terapéuticos activos sobre lacirculacion. La combinacion de las propiedades protectoras del corazon con terapias conocidas de enfermedades cardiocirculatorias conduce por unaparte a un mejoramiento de la calidad del tratamiento y por otra parte, en numerosas combinaciones, a un refuerzo aditivo o potenciador de losefectos sobre el corazon y la circulacion de los componentes individuales de efecto, tomados a solas. Un envase comercial que comprende dichopreparado farmacéutico combinado destinado al tratamiento de enfermedades cardiocirculatorias.
ARP980104222A 1997-08-27 1998-08-25 Preparado farmaceutico combinado que contiene un inhibidor del intercambiador entre sodio e hidrogeno y envase comercial destinado al tratamientode enfermedades cardiocirculatorias AR017513A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737224A DE19737224A1 (de) 1997-08-27 1997-08-27 Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen

Publications (1)

Publication Number Publication Date
AR017513A1 true AR017513A1 (es) 2001-09-12

Family

ID=7840257

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104222A AR017513A1 (es) 1997-08-27 1998-08-25 Preparado farmaceutico combinado que contiene un inhibidor del intercambiador entre sodio e hidrogeno y envase comercial destinado al tratamientode enfermedades cardiocirculatorias

Country Status (23)

Country Link
US (1) US6348476B1 (es)
EP (1) EP0937464B1 (es)
JP (1) JP4436940B2 (es)
KR (1) KR19990023904A (es)
CN (1) CN1172665C (es)
AR (1) AR017513A1 (es)
AU (1) AU738598B2 (es)
BR (1) BR9803233A (es)
CA (1) CA2245776A1 (es)
CZ (1) CZ270998A3 (es)
DE (1) DE19737224A1 (es)
HK (1) HK1018211A1 (es)
HR (1) HRP980464A2 (es)
HU (1) HUP9801924A3 (es)
IL (1) IL125913A0 (es)
NO (1) NO320264B1 (es)
NZ (1) NZ331533A (es)
PL (1) PL195566B1 (es)
RU (1) RU2227751C2 (es)
SK (1) SK116798A3 (es)
TR (1) TR199801661A2 (es)
TW (1) TW589175B (es)
ZA (1) ZA987723B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945302A1 (de) * 1999-09-22 2001-03-29 Merck Patent Gmbh Biphenylderivate als NHE-3-Inhibitoren
US6423705B1 (en) 2001-01-25 2002-07-23 Pfizer Inc. Combination therapy
IL147696A0 (en) * 2001-01-25 2002-08-14 Pfizer Prod Inc Combination therapy
RU2004126702A (ru) * 2002-02-04 2005-04-20 АВЕНТИС ФАРМА ДОЙЧЛАНД ГмбХ (DE) Комбинированный препарат на основе ингибитора натрий-водородного обмена карипорида с ингибиторами ангиотензинконвертирующего фермента для предотвращения сердечной недостаточности и других, обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни
US6844361B2 (en) 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
US7629493B2 (en) * 2003-05-06 2009-12-08 Merck Patent Gmbh Process for the crystallisation of guandinium salts
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
DE10356717A1 (de) * 2003-12-02 2005-07-07 Aventis Pharma Deutschland Gmbh Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten
US7531569B2 (en) * 2003-12-02 2009-05-12 Sanofi-Aventis Deutschland Gmbh Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives
CA2586547A1 (en) * 2004-11-05 2006-05-11 King Pharmaceuticals Research & Development, Inc. Stabilized individually coated ramipril particles, compositions and methods
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
EP3960165A1 (en) * 2020-08-25 2022-03-02 Fondation EspeRare Nhe-1 inhibitors for the treatment of coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE158278T1 (de) 1992-02-15 1997-10-15 Hoechst Ag Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
EP0589336B1 (de) * 1992-09-22 1997-01-08 Hoechst Aktiengesellschaft Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
DE4328869A1 (de) 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432106A1 (de) 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
DE19741635A1 (de) * 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Also Published As

Publication number Publication date
CA2245776A1 (en) 1999-02-27
RU2227751C2 (ru) 2004-04-27
PL195566B1 (pl) 2007-10-31
US6348476B1 (en) 2002-02-19
HU9801924D0 (en) 1998-10-28
IL125913A0 (en) 1999-04-11
JPH11139990A (ja) 1999-05-25
EP0937464A3 (de) 2003-09-24
ZA987723B (en) 1999-03-01
HUP9801924A3 (en) 2004-11-29
TR199801661A2 (xx) 1999-03-22
CZ270998A3 (cs) 1999-03-17
NO983926L (no) 1999-03-01
PL328251A1 (en) 1999-03-01
AU8190898A (en) 1999-03-11
CN1209316A (zh) 1999-03-03
NZ331533A (en) 2000-04-28
KR19990023904A (ko) 1999-03-25
BR9803233A (pt) 2000-05-02
NO320264B1 (no) 2005-11-14
HK1018211A1 (en) 1999-12-17
EP0937464A2 (de) 1999-08-25
TW589175B (en) 2004-06-01
DE19737224A1 (de) 1999-03-18
EP0937464B1 (de) 2012-07-11
JP4436940B2 (ja) 2010-03-24
HUP9801924A2 (hu) 2000-02-28
SK116798A3 (en) 1999-03-12
CN1172665C (zh) 2004-10-27
AU738598B2 (en) 2001-09-20
HRP980464A2 (en) 1999-06-30
NO983926D0 (no) 1998-08-26

Similar Documents

Publication Publication Date Title
AR017513A1 (es) Preparado farmaceutico combinado que contiene un inhibidor del intercambiador entre sodio e hidrogeno y envase comercial destinado al tratamientode enfermedades cardiocirculatorias
ES2550094T3 (es) Composiciones de N-acetilcisteína y métodos de tratamiento y de prevención de la toxicidad de los medicamentos
ES2036553T3 (es) Composiciones farmaceuticas que tienen actividad antineoplastica.
UY25791A1 (es) Combinaciones para la diabetes
UY30605A1 (es) Composiciones farmacéuticas acuosas autoconservadas
ES2169087T3 (es) Formulaciones orales de un antifungico.
PE20020307A1 (es) Forma de dosificacion de farmaco activada por hidrogel
GR3002487T3 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
ES2058420T3 (es) Preparados farmaceuticos combinados y su utilizacion como medicamentos antineoplasicos.
DE3484573D1 (de) Durchdringende topische pharmazeutische zusammensetzungen mit gehalt an n-(2-hydroxyethyl)-pyrrolidon.
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
AR014126A1 (es) Uso de una sal soluble de bismuto, un primer antibiotico y un segundo antibiotico y una forma de dosificacion faramaceutica
BR0214403A (pt) Composições farmacêuticas compreendendo metformina e glibenclamida para o tratamento de diabetes melittus tipo ii
FI955154A0 (fi) Viruskombinantteja ja niiden käyttö geeniterapiassa
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
DE69531098D1 (de) Piperidine und pyrrolidine
ES2056588T3 (es) Dosificador-distribuidor y procedimiento de dosificacion de un producto pastoso y/o liquido.
AR040036A1 (es) Tratamiento de la mucositis
BR0312782A (pt) Composição para o tratamento de manchas
SE8103369L (sv) Antiperspirantkomposition innehallande en aluminiumklorid och en aluminiumzirkoniumhydroxiklorid som aktiva bestandsdelar och sett att inhibera perspiration
AR018102A1 (es) Utilizacion de combinaciones farmaceuticas de al menos un antiemetico de eficacia procinetica, o de sales de aceptacion farmaceutica del mismo, ytramadol, sus enantiomeros o las sales de aceptacion farmaceutica, dichas combinaciones farmaceuticas y los medicamentos que contienen dichas combinaciones
AR005860A1 (es) Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización.
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.

Legal Events

Date Code Title Description
FB Suspension of granting procedure